-
PRESS RELEASEPRESS RELEASE
-
Our PipelineOUR PIPELINE
A series of first-in-class antibody drugs and biosimilars are currently under advanced clinical and nonclinical development stages. Based on scientific capabilities and innovative technologies, we are developing novel antibody therapeutics and biosimilar drugs.
-
Our TechnologyR&D
Prestige Biopharma facilitates pharmaceutical R&D activities through well-equipped multidisciplinary infrastructure ranging from discovery through preclinical and clinical development.
-
Discovery and Development of
Future BiologicsWith decades of R&D and operational experience in drug discovery, Prestige Biopharma expedites future biologics development.
Our pipeline includes various novel antibody drugs with high potential. -
A frontier in
BiopharmaceuticalsPrestige Biopharma is paving the way to become a global leading biopharmaceutical. Armed with proprietary technology and scientific capability, we are growing fast as a frontier in biopharmaceuticals. -
Creating Differences &
Value for Human HealthPrestige Biopharma strives to improve access and affordability of biologic drugs. Our biosimilars provide effective treatment at a lower cost to help more people suffering from devastating diseases. -
Innovation for LifePrestige Biopharma’s mission is to better lives, especially of those with unmet medical needs, by developing innovative first-in-class biologics, high-quality biosimilars, and next-generation vaccines.